Track topics on Twitter Track topics that are important to you
Immunotherapies targeting immune checkpoints such as CTLA4, PDCD1 (PD-1), and CD274 (PD-L1) have revolutionised oncology.1 High-level microsatellite instability (MSI-high) caused by mismatch repair deficiency is routinely used as a biomarker to predict response to immune-checkpoint blockade.2 MSI-high status in colorectal carcinoma correlates with tumour neoantigen loads, which in turn correlate with immune response.3 Combined analysis of tumoural and immune factors (eg, the so-called Tumour Immunity in the MicroEnvironment [TIME] classification) could be a new cancer classification system.
Original Article: [Comment] Immunoscore for (colorectal) cancer precision medicineNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...